BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wen Y, Gorsic LK, Wheeler HE, Ziliak DM, Huang RS, Dolan ME. Chemotherapeutic-induced apoptosis: a phenotype for pharmacogenomics studies. Pharmacogenet Genomics 2011;21:476-88. [PMID: 21642893 DOI: 10.1097/FPC.0b013e3283481967] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Njiaju UO, Gamazon ER, Gorsic LK, Delaney SM, Wheeler HE, Im HK, Dolan ME. Whole-genome studies identify solute carrier transporters in cellular susceptibility to paclitaxel. Pharmacogenet Genomics 2012;22:498-507. [PMID: 22437668 DOI: 10.1097/FPC.0b013e328352f436] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
2 Ziliak D, Gamazon ER, Lacroix B, Kyung Im H, Wen Y, Huang RS. Genetic variation that predicts platinum sensitivity reveals the role of miR-193b* in chemotherapeutic susceptibility. Mol Cancer Ther 2012;11:2054-61. [PMID: 22752226 DOI: 10.1158/1535-7163.MCT-12-0221] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
3 Ko DC, Urban TJ. Understanding human variation in infectious disease susceptibility through clinical and cellular GWAS. PLoS Pathog 2013;9:e1003424. [PMID: 23935492 DOI: 10.1371/journal.ppat.1003424] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
4 Stark AL, Delaney SM, Wheeler HE, Im HK, Dolan ME. Functional consequences of PRPF39 on distant genes and cisplatin sensitivity. Hum Mol Genet 2012;21:4348-55. [PMID: 22773733 DOI: 10.1093/hmg/dds266] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
5 Leandro-García LJ, Leskelä S, Jara C, Gréen H, Avall-Lundqvist E, Wheeler HE, Dolan ME, Inglada-Perez L, Maliszewska A, de Cubas AA, Comino-Méndez I, Mancikova V, Cascón A, Robledo M, Rodríguez-Antona C. Regulatory polymorphisms in β-tubulin IIa are associated with paclitaxel-induced peripheral neuropathy. Clin Cancer Res 2012;18:4441-8. [PMID: 22718863 DOI: 10.1158/1078-0432.CCR-12-1221] [Cited by in Crossref: 49] [Cited by in F6Publishing: 30] [Article Influence: 4.9] [Reference Citation Analysis]
6 Huang C, Mezencev R, McDonald JF, Vannberg F. Open source machine-learning algorithms for the prediction of optimal cancer drug therapies. PLoS One 2017;12:e0186906. [PMID: 29073279 DOI: 10.1371/journal.pone.0186906] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 8.6] [Reference Citation Analysis]
7 Madian AG, Wheeler HE, Jones RB, Dolan ME. Relating human genetic variation to variation in drug responses. Trends Genet 2012;28:487-95. [PMID: 22840197 DOI: 10.1016/j.tig.2012.06.008] [Cited by in Crossref: 51] [Cited by in F6Publishing: 39] [Article Influence: 5.1] [Reference Citation Analysis]
8 Moen EL, Godley LA, Zhang W, Dolan ME. Pharmacogenomics of chemotherapeutic susceptibility and toxicity. Genome Med 2012;4:90. [PMID: 23199206 DOI: 10.1186/gm391] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
9 Zhou W, Fu XQ, Zhang LL, Zhang J, Huang X, Lu XH, Shen L, Liu BN, Liu J, Luo HS, Yu JP, Yu HG. The AKT1/NF-kappaB/Notch1/PTEN axis has an important role in chemoresistance of gastric cancer cells. Cell Death Dis 2013;4:e847. [PMID: 24113181 DOI: 10.1038/cddis.2013.375] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 3.9] [Reference Citation Analysis]
10 Im HK, Gamazon ER, Stark AL, Huang RS, Cox NJ, Dolan ME. Mixed effects modeling of proliferation rates in cell-based models: consequence for pharmacogenomics and cancer. PLoS Genet 2012;8:e1002525. [PMID: 22346769 DOI: 10.1371/journal.pgen.1002525] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
11 Gorsic LK, Stark AL, Wheeler HE, Wong SS, Im HK, Dolan ME. EPS8 inhibition increases cisplatin sensitivity in lung cancer cells. PLoS One 2013;8:e82220. [PMID: 24367505 DOI: 10.1371/journal.pone.0082220] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
12 Grassi MA, Rao V, Winkler KP, Zhang W, Bogaard JD, Chen S, LaCroix B, Lenkala D, Rehman J, Malik AB, Cox NJ, Huang RS. Genetic variation is the major determinant of individual differences in leukocyte endothelial adhesion. PLoS One 2014;9:e87883. [PMID: 24520339 DOI: 10.1371/journal.pone.0087883] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
13 Wheeler HE, Dolan ME. Lymphoblastoid cell lines in pharmacogenomic discovery and clinical translation. Pharmacogenomics 2012;13:55-70. [PMID: 22176622 DOI: 10.2217/pgs.11.121] [Cited by in Crossref: 79] [Cited by in F6Publishing: 75] [Article Influence: 7.9] [Reference Citation Analysis]
14 Roselli G, Martini E, Lougaris V, Badolato R, Viola A, Kallikourdis M. CXCL12 Mediates Aberrant Costimulation of B Lymphocytes in Warts, Hypogammaglobulinemia, Infections, Myelokathexis Immunodeficiency. Front Immunol 2017;8:1068. [PMID: 28928741 DOI: 10.3389/fimmu.2017.01068] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
15 Gamazon ER, Lamba JK, Pounds S, Stark AL, Wheeler HE, Cao X, Im HK, Mitra AK, Rubnitz JE, Ribeiro RC, Raimondi S, Campana D, Crews KR, Wong SS, Welsh M, Hulur I, Gorsic L, Hartford CM, Zhang W, Cox NJ, Dolan ME. Comprehensive genetic analysis of cytarabine sensitivity in a cell-based model identifies polymorphisms associated with outcome in AML patients. Blood 2013;121:4366-76. [PMID: 23538338 DOI: 10.1182/blood-2012-10-464149] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]